INGUS AS • 977065097 • Oslo • Real estate activities

This website uses cookies to enhance the user experience.

INGUS AS

Keywords

real estatetenementshomesbuildingsexhibition hallswarehousesshopping centresland propertiessubdivision

Organization

CEO: IM
Inga Margrethe Ulstein Loen1963
Chairman of the board: IM
Inga Margrethe Ulstein Loen1963
Years since formation: 27 years; since Jan 8, 1997
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 92,000; 1 share class
Total number of shareholders: 1; person

Financials

Annual total result 2023: -505,841; NOK
Total equity 2023: 31,273,179; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
IM Inga Margrethe Ulstein Loen 1963	Managing Director/CEO	100 % directly

Board

Name	Role	Shares
IM Inga Margrethe Ulstein Loen 1963	Chairman	100 % directly
LL Line Knivsflå Loen 1965	Alternate Member	-

Others

Name	Role	Shares
B BDO AS	Auditor	-
H HASUND AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
IM Inga Margrethe Ulstein Loen 1963	Managing Director/CEO, Chairman	100 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
IM Inga Margrethe Ulstein Loen 1963	Ordinary shares	92,000	100 %

Shares owned by the INGUS AS

Name	Share class	Number of shares	Share
B BOJO SHIPPING AS	Ordinary shares	33,000	3 %
I ISLAND OFFSHORE V AS	Ordinary shares	4,090	1.75 %
U ULSTEIN HOTELL AS	Ordinary shares	75,509	1.65 %
U ULSTEINVIK UTVIKLING AS	Ordinary shares	730	1.59 %
A ALLIANCE VENTURE POLARIS AS	A-shares	60,276	1.39 %
I ISLAND OFFSHORE XI AS	Ordinary shares	3,595,295	1.35 %
I ISLAND OFFSHORE VIII AS	Ordinary shares	336,636	0.92 %
I ISLAND OFFSHORE XII AS	Ordinary shares	22,000	0.85 %
U ULSTEIN GROUP ASA	NO0010003429	4,883,285	0.74 %
A AS HOTEL ALEXANDRA	Ordinary shares	1,075	0.47 %
B BYGGMA ASA	NO0003087603	175,760	0.25 %
P PCI BIOTECH HOLDING ASA	NO0010405640	24,480	0.07 %
L LYTIX BIOPHARMA AS	NO0010405780	15,000	0.04 %
A AMICOAT AS	NO0010799679	8,468	0.03 %
P PHARMASUM THERAPEUTICS AS	Ordinary shares	798	0.03 %
P PHARMA HOLDINGS AS	NO0010797350	169	0.02 %
N NORDIC HALIBUT AS	NO0003058109	160	< 0.01 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	0
Annual Total Result	-505,841	-1,658,705	7,184,637
Total assets	31,289,979	31,896,952	36,574,126
Total liabilities	16,801	117,932	3,136,401
Total equity	31,273,179	31,779,020	33,437,725

P&L

Year	2023	2022	2021
Total operating income	0	0	0
Total operating costs	40,112	172,803	145,461
Operating result	-40,112	-172,803	-145,461
Financial income/costs	-465,729	-1,485,903	7,330,098
Profit before tax	-505,841	-1,658,705	7,184,637
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-505,841	-1,658,705	7,184,637

Balance overview

Year	2023	2022	2021
Total fixed assets	12,264,840	12,673,784	13,282,187
Total current assets	19,025,139	19,223,168	23,291,938
Total assets	31,289,979	31,896,952	36,574,126
Short term debt	16,801	117,932	3,136,401
Long term debt	0	0	0
Total liabilities	16,801	117,932	3,136,401
Contributed capital	5,474,000	5,474,000	5,474,000
Retained earnings	25,799,179	26,305,020	27,963,725
Total equity	31,273,179	31,779,020	33,437,725
Total equity and liabilities	31,289,979	31,896,952	36,574,126

Classification

Category

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

L

Main industrial area

Real estate activities

68

Activity

Real estate activities

68.1

Main industrial group

Buying and selling of own real estate

68.10

Industrial group

Buying and selling of own real estate

68.100

Industrial group

Buying and selling of own real estate